VBI Vaccines (VBIVQ) 10-K2023 FY Annual report

Filed: 16 Apr 24, 8:01am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: AASLD, acknowledge, al, APAC, attrition, bearing, black, book, cabinet, campaign, cellular, clash, concurrent, constitute, constituted, consummated, consummation, conveyance, correspondingly, covenant, daily, DCR, distancing, durability, durable, endemic, enrich, entry, EoT, essential, expert, expressly, extortion, float, forbear, forbearance, foreclosure, fractional, fundamentally, Gilboa, headcount, humoral, IIb, incident, inclined, indemnify, indemnity, lieu, Medicenna, methodology, MLE, morale, movement, obsolescence, organizational, outflow, oversee, overseen, pangolin, parallel, payroll, perfected, peripheral, placement, poster, pretax, progression, promissory, proportionate, provoking, Raymond, reclassification, reclassify, Red, refrain, reorganization, reset, retroactively, rocket, routine, safeguard, scenario, Sea, Seller, seroconversion, SoC, southern, Subordination, unblinded, unrestricted, Vaughn, vendor, Vigeo, vivo, Wainwright, wane

Removed: academia, acceleration, accommodate, acted, AG, Allawite, AMM, amortization, amounted, anniversary, antiviral, automatic, Autorisation, backed, begun, cancellation, chemical, Christopher, clone, concentration, confer, consolidate, coup, CRO, Dicerna, dissolution, DNAtrix, earned, escalated, eventual, extremist, finite, fired, gB, Gilead, Hookipa, insolvent, intervention, involuntary, Iran, Islamist, Jeff, Johnson, lacking, le, Lebanese, liquidation, LP, lump, McNulty, merge, militia, mise, missile, Mitsubishi, nuclear, oncolytic, oppose, outbreak, owing, PCOF, Perceptive, permitting, planning, precautionary, predicted, readily, reallocate, rebel, redeem, redeemable, redeemed, relaxed, repayable, repurchase, revised, Roche, Scientist, seized, shelf, Shiite, SPA, sublicensee, sublicensing, subsided, sum, summer, sur, surfaced, symptomatic, Syria, Takeda, Tanabe, terminating, thermostability, thermostable, toxicological, Transgene, turbulence, unadjuvanted, Universite, vi, vir, visit, waived

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

VBIVQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

In connection with the annual report of VBI Vaccines Inc. (the “Company”) on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, Jeffrey Baxter, Chief Executive Officer (Principal Executive Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: April 16, 2024

/s/ Jeffrey Baxter
Jeffrey Baxter
Chief Executive Officer (Principal Executive Officer)